An abnormal CD34+ myeloid/CD34+ lymphoid ratio at the end of chemotherapy predicts relapse in patients with acute myeloid leukemia. [electronic resource]
Producer: 19990629Description: 70-5 p. digitalISSN:- 0196-4763
- Adolescent
- Adult
- Aged
- Antigens, CD34 -- immunology
- Antineoplastic Agents -- therapeutic use
- Bone Marrow Cells -- immunology
- Child
- Female
- Hematopoietic Stem Cells -- immunology
- Humans
- Immunophenotyping
- Leukemia, Myeloid -- drug therapy
- Lymphocytes -- immunology
- Male
- Middle Aged
- Predictive Value of Tests
- Prognosis
- Recurrence
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.